UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 75 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 5.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | -6.2% | 39,704 | +38.6% | 0.00% | – |
| Q2 2022 | $16,000 | -74.2% | 28,654 | +1.5% | 0.00% | – |
| Q1 2022 | $62,000 | +87.9% | 28,241 | +26.5% | 0.00% | – |
| Q4 2021 | $33,000 | -49.2% | 22,332 | +1.5% | 0.00% | – |
| Q3 2021 | $65,000 | -44.0% | 22,001 | -13.1% | 0.00% | – |
| Q2 2021 | $116,000 | -48.0% | 25,310 | -32.0% | 0.00% | -100.0% |
| Q1 2021 | $223,000 | +869.6% | 37,210 | +750.3% | 0.00% | – |
| Q4 2020 | $23,000 | +91.7% | 4,376 | +33.2% | 0.00% | – |
| Q3 2020 | $12,000 | -70.7% | 3,286 | -30.8% | 0.00% | – |
| Q2 2020 | $41,000 | +4000.0% | 4,746 | +4646.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |